Background illustration for clinical trials search

Paid Clinical Trials Spokane

Discover 241 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Location: Spokane WA, Walla Walla WA, Kennewick WA, Yakima WA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase2, Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Spokane WA, Lakewood CO, Denver CO, Aurora CO,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Spokane WA, Portland OR, Springfield OR, Sacramento CA,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Spokane WA, Lakewood CO, Aurora CO, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Spokane WA, Calgary, Portland OR, Fresno CA, Denver CO,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

for
Non-Muscle Invasive Bladder Neoplasms
Location: Spokane WA, Seattle WA, Lakewood CO, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07309445

Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Spokane WA, Springfield OR, Fresno CA, Lakewood CO,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Spokane WA, Abbotsford British Columbia, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

for
Moderate-to-severe Chronic Plaque Psoriasis
Location: Spokane WA, Fremont CA, Glendale AZ, San Antonio TX,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07362017

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Spokane WA, Kirkland WA, Portland OR, Denver CO,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase2, Recruiting

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

for
Multiple System Atrophy
Location: Spokane WA, La Jolla CA, Kansas City KS, Chicago IL,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 30+

Code: NCT07197866

Phase2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Spokane WA, Kelowna, Victoria, Boise ID, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Spokane WA, Fort Wayne IN, Nashville TN, Buffalo NY,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT06150664

Phase1, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Spokane WA, Seattle WA, Salt Lake City UT,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase1, Phase2, Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Spokane WA, Seattle WA, Aurora CO, Los Angeles CA,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase1, Phase2, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Spokane WA, Olympia WA, Portland OR, Eugene OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

for
CLL / SLL, CLL (Chronic Lymphocytic Leukemia), CLL, Refractory,
Location: Spokane WA, Las Vegas NV, Skokie IL, Bethesda MD
Sponsor: Newave Pharmaceutical Inc

Sex: All

Age: 18+

Code: NCT07342478

Phase3, Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Spokane WA, West Valley City UT, Fort Worth TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Spokane WA, Seattle WA, Tacoma WA, Roseville CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Spokane WA, Kalispell MT, Bend OR, Reno NV,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06899126

Phase3, Recruiting